Reconstitution, Storage and Cold Chain for New Zealand Laboratories

Most peptide degradation happens after delivery, not before it. This is the handling protocol we give New Zealand labs, including the concentration maths and the freeze-thaw rules that matter most.

Suppliers spend a great deal of energy proving purity at the point of dispatch. Far less attention goes to what happens in the two weeks after a vial reaches a bench, which is where the majority of avoidable potency loss actually occurs. This protocol is written for New Zealand conditions specifically: coastal humidity, older lab buildings with limited climate control, and rural delivery legs that add a day to transit.

Before you open anything

Let the vial equilibrate to room temperature before removing the stopper. Opening a vial straight out of a -20 °C freezer draws humid New Zealand air onto a cold surface, and the resulting condensation begins hydrolysing the cake immediately. Twenty minutes on the bench in a sealed container costs nothing and prevents the most common handling error we see reported.

Choosing your diluent

The concentration calculation

The arithmetic is simple and consistently mis-applied. Concentration equals peptide mass divided by diluent volume. A 10 mg vial reconstituted with 2 mL of bacteriostatic water yields 5 mg per mL, which is 5000 micrograms per mL, or 500 micrograms per 0.1 mL graduation on a standard 1 mL syringe. Write the resulting concentration on the vial in permanent marker at the moment you reconstitute — not later, and not on a separate sheet.

1. Wipe the stopper with isopropyl alcohol and let it dry fully before piercing.
2. Draw your measured diluent volume and introduce it slowly against the inner glass wall, never directly onto the cake.
3. Let the cake dissolve on its own. Swirl gently if needed after two minutes.
4. Never shake or vortex. Mechanical shear and the resulting foam denature peptide chains and are a leading cause of silent potency loss.
5. Label the vial with concentration and reconstitution date, then move it to 2–8 °C.

Storage windows we recommend

Freeze-thaw is the enemy

Reconstituted peptide should never be refrozen. Each freeze-thaw cycle drives ice-crystal formation that mechanically disrupts the chain and drops measurable activity. If a study design requires long-term storage of solution, aliquot into single-use volumes at the moment of reconstitution and freeze the aliquots once. Thaw each aliquot in the fridge rather than under warm water.

A note on New Zealand humidity

Coastal Auckland, Northland and much of the Bay of Plenty run high ambient humidity for large parts of the year. Lyophilised cakes are hygroscopic, and an unstoppered vial in a humid room absorbs water measurably within minutes. Work quickly, keep desiccant in your freezer boxes, and avoid reconstituting near an open window on a damp day. These are small habits that show up in the consistency of your data.

Handling questions

Why Peptide reconstitution storage matters to research labs

New Zealand research teams evaluating peptide reconstitution storage face three recurring questions before any in-vitro work begins: is the compound what the label claims, will it remain stable across the planned experimental window, and does the supplier's documentation hold up to the standards a principal investigator will sign off on. The remainder of this article is structured around those three questions.

New Zealand Peptides supplies peptide reconstitution storage as a lyophilised research material packaged for transit at ambient temperatures and long-term storage at −20 °C. Every batch ships with a lot-specific certificate of analysis covering identity, purity, residual solvents and endotoxin where downstream cell culture work is anticipated.

Typical research applications

Across the published literature, peptide reconstitution storage appears most often in three workflow categories. Each has its own documentation profile and storage requirements, which is why a single supplier batch is frequently subdivided across multiple aliquots to limit freeze-thaw cycling.

• In-vitro receptor binding and signalling characterisation, where milligram-scale aliquots are reconstituted fresh on the day of assay.
• Pharmacokinetic and stability modelling, where reconstituted material is sampled at defined time-points and analysed by RP-HPLC.
• Comparative reference work, where peptide reconstitution storage is benchmarked against in-house standards or other published research compounds.

Certificate of analysis — what to verify

Every New Zealand Peptides peptide reconstitution storage lot is dispatched with a certificate of analysis (COA) tied to the batch identifier printed on the vial. Reviewing the COA before the material enters the workflow is the single highest-leverage quality control step a research lab can perform.

• Batch / lot identifier and synthesis date — both must match the vial.
• RP-HPLC purity, typically ≥98% for research-grade peptide reconstitution storage.
• Mass-spectrometry identity confirmation (LC-MS or MALDI-TOF) within ±0.5 Da of the theoretical mass.
• Counterion identity and percent (acetate or trifluoroacetate are the most common).
• Bacterial endotoxin per the published analytical method, reported in EU/mg.
• Residual solvents and water content where the synthesis route makes them analytically meaningful.

Quality benchmarks New Zealand Peptides publishes

Frequently asked research questions

Further reading

Continue with the related New Zealand Peptides research references linked at the foot of this article, or browse the full research catalogue for the compound class profile, lab-results archive and laboratory documentation. For sourcing questions, the research team is available via the New Zealand Peptides contact page.